Clinical Trial Detail

NCT ID NCT02365818
Title Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade Non-Muscle Invasive Bladder Cancer After BCG Failure
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cold Genesys, Inc.
Indications

urethra transitional cell carcinoma

urinary bladder cancer

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Therapies

CG0070

Age Groups: adult

No variant requirements are available.